Lilleby W, Seierstad T, Inderberg EM, Hole KH(2023) Impact of hTERT peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring Int J Cancer(in press) DOI 10.1002/ijc.34448, PubMed 36715014
Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A(2022) Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma Front Med (Lausanne), 9, 1058863 DOI 10.3389/fmed.2022.1058863, PubMed 36507500
Maggadóttir SM, Kvalheim G, Wernhoff P, Sæbøe-Larssen S, Revheim ME, Josefsen D, Wälchli S, Helland Å, Inderberg EM(2022) A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT) Front Oncol, 12, 1031232 DOI 10.3389/fonc.2022.1031232, PubMed 36439452
